
Cabio
688089.SSCabio Biotech (Wuhan) Co., Ltd. Price (688089.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
169,211,417
(0.7211)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People's Republic of China. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $12.04-30.12
- Market Cap 4.49B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Dewei Yi
- IPO Date: December, 19, 2019
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 508
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
